Pirk J - Search Results

1

Safety and Efficacy of Immunoadsorption in Heart Transplantation Program.

Gazdic T, Malek I, Pagacova L, Slavcev A, Voska L, Hegarova M, Hoskova L, Kubanek M, Pirk J. Gazdic T, et al. Among authors: pirk j. Transplant Proc. 2016 Oct;48(8):2792-2796. doi: 10.1016/j.transproceed.2016.06.061. Transplant Proc. 2016. PMID: 27788819

2

Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance.

Svobodova E, Gazdic T, Kubanek M, Vymetalova J, Voska L, Kment M, Lanska V, Kolesar L, Urban M, Netuka I, Pirk J, Melenovsky V, Kautzner J, Slavcev A, Malek I. Svobodova E, et al. Among authors: pirk j. Transpl Int. 2016 Jan;29(1):63-72. doi: 10.1111/tri.12684. Epub 2015 Sep 22. Transpl Int. 2016. PMID: 26340387 Free article.

3

The effect of cyclosporin A on the level of big endothelin in patients one year after orthotopic heart transplantation.

Kocík M, Málek I, Glagolicová A, Pirk J. Kocík M, et al. Among authors: pirk j. Transpl Int. 2004 Feb;17(2):65-70. doi: 10.1007/s00147-003-0666-3. Epub 2003 Nov 22. Transpl Int. 2004. PMID: 14634722 Free article.

4

Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.

Kocík M, Málek I, Janek B, Zelízko M, Pirk J. Kocík M, et al. Among authors: pirk j. Transpl Int. 2007 Aug;20(8):666-74. doi: 10.1111/j.1432-2277.2007.00484.x. Epub 2007 May 23. Transpl Int. 2007. PMID: 17521382 Free article.

5

Myxoma of donor origin in a transplanted heart.

Dufková B, Málek I, Vymetalová Y, Hosková L, Skalský I, Pirk J, Vrbská J, Marek T, Bohuslavová R, Hubácek J, Kautzner J. Dufková B, et al. Among authors: pirk j. J Heart Lung Transplant. 2007 Aug;26(8):865-7. doi: 10.1016/j.healun.2007.05.021. J Heart Lung Transplant. 2007. PMID: 17692794

6

Heart transplantations at the Heart Center IKEM, Prague, Czech Republic.

Pirk J, Malek I, Netuka I, Hoskova L, Pokorna E, Kotulak T, Urban M. Pirk J, et al. Clin Transpl. 2012:135-43. Clin Transpl. 2012. PMID: 23721016

7

Ischaemic heart disease is a risk factor for renal failure after heart transplantation.

Hosková L, Viklický O, Málek I, Podzimková M, Hegarová M, Pirk J, Vítko S, Kautzner J. Hosková L, et al. Among authors: pirk j. Int J Cardiol. 2008 Jan 24;123(3):358-60. doi: 10.1016/j.ijcard.2006.11.187. Epub 2007 Mar 13. Int J Cardiol. 2008. PMID: 17360057

8

Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome.

Urban M, Gazdic T, Slimackova E, Pirk J, Szarszoi O, Maly J, Netuka I. Urban M, et al. Among authors: pirk j. ASAIO J. 2012 Nov-Dec;58(6):554-61. doi: 10.1097/MAT.0b013e31826d6070. ASAIO J. 2012. PMID: 23069898

9

Non-Fontan Adult Congenital Heart Disease Transplantation Survival Is Equivalent to Acquired Heart Disease Transplantation Survival.

Besik J, Szarszoi O, Hegarova M, Konarik M, Smetana M, Netuka I, Pirk J, Maly J. Besik J, et al. Among authors: pirk j. Ann Thorac Surg. 2016 May;101(5):1768-73. doi: 10.1016/j.athoracsur.2015.10.088. Epub 2016 Feb 6. Ann Thorac Surg. 2016. PMID: 26857637

10

[Electrocardiographic changes after heart transplantation].

Hosková L, Málek I, Krausová R, Podzimková M, Pirk J. Hosková L, et al. Among authors: pirk j. Vnitr Lek. 2002 Dec;48 Suppl 1:72-5. Vnitr Lek. 2002. PMID: 12744023 Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page